FDA approves Elan's Prialt

FDA approved ELN's Prialt ziconotide intrathecal infusion to treat severe chronic pain. In

Read the full 131 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE